Literature DB >> 422247

Human cell-mediated immune responses to chlamydial antigens.

L Hanna, L Schmidt, M Sharp, D P Stites, E Jawetz.   

Abstract

A reproducible method was developed to determine the ability of chlamydial antigens to stimulate lymphocytes from volunteers. In tests repeated 4 to 14 times, the cells from a given volunteer gave a relatively narrow range of responses, but there were great differences in the mean response of different volunteers. In the entire group of 52 volunteers, lymphocyte stimulation was significantly associated with the presence of antibody, but in a given individual results of one test did not aid in predicting the results of the other. A majority of persons with either antichlamydial antibody or elevated lymphocyte stimulation, or both, did not have a history of signs or symptoms within a spectrum of chlamydial diseases. This may reflect the great frequency of asymptomatic infection with these organisms. The lymphocytes of some individuals were stimulated to a significantly greater degree by antigens of one chlamydial species (Chlamydia trachomatis or C. psittaci) than by the other. These and other cell-mediated reactions in human chlamydial infections, and their possible medical significance, are under continued study.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 422247      PMCID: PMC414180          DOI: 10.1128/iai.23.2.412-417.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  A simple method for total particle counts of trachoma and inclusion blennorrhoea viruses.

Authors:  P REEVE; J TAVERNE
Journal:  Nature       Date:  1962-09-01       Impact factor: 49.962

2.  Are chlamydial infections the most prevalent venereal disease?

Authors:  J Schachter; L Hanna; E C Hill; S Massad; C W Sheppard; J E Conte; S N Cohen; K F Meyer
Journal:  JAMA       Date:  1975-03-24       Impact factor: 56.272

Review 3.  Chlamydial infections (third of three parts).

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

4.  Antibodies to TRIC agents in tears and serum of naturally infected humans.

Authors:  L Hanna; E Jawetz; O C Briones; H Keshishyan; I Hoshiwara; H B Ostler; C R Dawson
Journal:  J Infect Dis       Date:  1973-01       Impact factor: 5.226

5.  Immunity to chlamydial infections of the eye. I. The role of circulatory and secretory antibodies in resistance to reinfection with guinea pig inclusion conjunctivitis.

Authors:  E S Murray; L T Charbonnet; A B MacDonald
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

6.  Titration and typing of serum antibodies in TRIC infections by immunofluorescence.

Authors:  L Hanna; E Jawetz; B Nabli; I Hoshiwara; B Ostler; C Dawson
Journal:  J Immunol       Date:  1972-01       Impact factor: 5.422

7.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

8.  Immunity to chlamydial infections of the eye. 3. Presence and duration of delayed hypersensitivity to guinea pig inclusion conjuctivitis.

Authors:  R R Watson; A B MacDonald; E S Murray; F Z Modabber
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

9.  Whole-blood lymphocyte stimulation assay for measurement of cell-mediated immune responses in bovine brucellosis.

Authors:  J M Kaneene; R K Anderson; D W Johnson; C C Muscoplat; P Nicoletti; R D Angus; D E Pietz; D J Klausner
Journal:  J Clin Microbiol       Date:  1978-06       Impact factor: 5.948

10.  Human chorionic gonadotropin: effects of crude and purified preparations on lymphocyte responses to phytohemagglutinin and allogenenic stimulation.

Authors:  J L Caldwell; D P Stites; H H Fudenberg
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

View more
  23 in total

1.  T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Authors:  X Yang; R Brunham
Journal:  Can J Infect Dis       Date:  1998-03

2.  Antichlamydial specificity of conjunctival lymphocytes during experimental ocular infection.

Authors:  J A Whittum-Hudson; H R Taylor
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

3.  Peripheral blood T cell proliferative response to chlamydial organisms in gonococcal and non-gonococcal urethritis and presumed pelvic inflammatory disease.

Authors:  M Shahmanesh; M Brunst; A Sukthankar; J H Pearce; J S Gaston
Journal:  Sex Transm Infect       Date:  1999-10       Impact factor: 3.519

4.  Trachoma: an overview.

Authors:  K F Tabbara
Journal:  Int Ophthalmol       Date:  1988       Impact factor: 2.031

5.  Treatment of uncomplicated anogenital gonorrhoea with a single oral dose of 3 g amoxycillin combined with 250 mg clavulanic acid.

Authors:  A H De Silva; S A Bashi; R Basu Roy
Journal:  Br J Vener Dis       Date:  1984-04

6.  T cell proliferative responses to Chlamydia trachomatis antigen in vitro in patients with a history of gynaecological chlamydia infection.

Authors:  E Qvigstad; M Onsrud; K Skaug
Journal:  Br J Vener Dis       Date:  1984-04

7.  Pelvic inflammatory disease in patients infected with Chlamydia trachomatis: in vitro cell mediated immune response to chlamydial antigens.

Authors:  T Hallberg; P Wölner-Hanssen; P A Mårdh
Journal:  Genitourin Med       Date:  1985-08

8.  Polyclonal response of human lymphocytes to Chlamydia trachomatis.

Authors:  L Räsänen; M Lehtinen; M Lehto; J Paavonen; P Leinikki
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

9.  Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis.

Authors:  R G Rank; H J White; A L Barron
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

10.  Cytotoxic cells induced after Chlamydia psittaci infection in mice.

Authors:  J K Lammert
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.